After a stroke

Spasticity and tight muscles: what it is and the treatments guidelines describe

Spasticity is increased muscle tightness associated with altered signals in the nervous system. A defining feature is greater resistance when a muscle is stretched more quickly, as this description of spasticity explains. It can follow a stroke or occur with cerebral palsy. The treatment discussion concerns the child's function and goals, as well as the tightness itself.

In brief

  • Spasticity concerns signals controlling movement; it can occur alongside weakness and difficulty controlling a limb.
  • Assessment looks at comfort, movement, daily activities, and the child’s and family’s priorities.
  • Guidelines describe therapy, braces or splints, medicines, injections, and surgery as categories of care.
  • Research about a treatment concerns specific goals and groups; it does not select a treatment for an individual child.

Why muscles can feel tight after a brain injury

Spasticity is associated with injury to pathways in the brain or spinal cord that control movement, as the description of spasticity explains. The balance of signals reaching muscles changes. Stroke and cerebral palsy are among the conditions it names. Although the effect is felt in a muscle, the explanation includes the nervous system's control of that muscle. Tightness is therefore not simply a description of muscle strength.

The National Institute of Neurological Disorders and Stroke (NINDS) describes stiff muscles and exaggerated reflexes in spastic cerebral palsy in its CP overview. Cerebral palsy is a condition affecting movement and posture because of changes in the developing brain. Its spastic hemiplegic pattern can involve an arm and hand, and sometimes a leg. The page on cerebral palsy explains the diagnosis and its different movement patterns.

The spasticity description also includes weakness, reduced movement control, and reduced endurance among changes that can occur alongside spasticity. Endurance means the ability to keep an activity going. These findings are not interchangeable. A clinician's assessment can distinguish a muscle's response to being moved from the child's own ability to reach, stand, walk, or carry out another activity.

Assessment starts with more than a tight muscle

The description of assessment includes posture, active movement, strength, coordination, endurance, and symptoms such as pain. It explains that clinicians feel the resistance of a relaxed muscle as it is moved. This is a clinical assessment, not a set of movements to try at home. The examination can help distinguish spasticity from other reasons for resistance or restricted movement.

The National Institute for Health and Care Excellence (NICE) describes a coordinated network of professionals in its spasticity recommendations. It includes medical and nursing expertise, physical and occupational therapy, and access to orthotics, surgery, and neurology expertise. Orthotics is the field concerned with supports such as braces. The care-team overview explains how the therapy roles fit together.

NICE says a management program should be individual, focused on goals, and developed with the child and parents or carers in its principles of care. It also calls for considering the effect of the program on family life. That gives practical context to a treatment discussion: a change in muscle tone is not the only possible goal. Comfort, activity, participation, and how a plan fits the child's needs all belong in the assessment.

The categories covered by guidelines

The NICE guideline overview includes physical and occupational therapy, orthoses, medicines taken by mouth, botulinum toxin treatment, and surgery among its categories. The following descriptions introduce their scope. They do not form a treatment order, show which option is preferable, or suggest that every child needs each category. The child's own clinicians consider the individual circumstances.

Physical and occupational therapy

NICE describes therapy programs tailored to particular goals, including skill development, everyday function, participation, and avoiding problems such as pain or contractures, in its physical therapy recommendations. A contracture is lasting shortening that restricts movement, as the NHS treatment overview explains. NICE includes stretching and positioning strategies, but the program and the training involved are individual clinical matters.

The same NICE recommendations call for discussing potential benefits alongside difficulties such as discomfort and the time and effort involved. They describe reassessment of whether goals are being achieved and whether the program remains appropriate. The page on physical therapy explains the movement assessment and therapy category without giving exercises or a home schedule.

Orthoses and splints

Orthoses are supports such as arm or leg braces, in the NHS explanation. NICE discusses their possible roles in posture, function, comfort, and joint position in its orthoses recommendations. It also emphasizes individual design and fitting. The category name does not specify a device or how it should be used for a child.

The NICE discussion includes possible discomfort, pressure sores, and muscle wasting from lack of muscle use among matters to weigh. It also considers whether an orthosis makes daily care or hygiene more difficult and whether its appearance is acceptable to the child. These are concrete examples of why equipment is discussed in relation to everyday life, not only limb position.

Medicines, injections, and surgery

NICE includes oral medicines, meaning medicines taken by mouth, in its guideline overview. The NHS treatment page describes medicines for muscle stiffness as tablets or liquids. These sources describe a treatment category; they do not provide a reason for a family to start, stop, or change a medicine. The clinical discussion includes its intended purpose and possible adverse effects.

Botulinum toxin injections are a medical treatment directed into selected muscles or muscle groups, as the NHS overview describes. The substance is a toxin made by bacteria; medical use involves a strongly diluted form that affects signaling between nerves and muscles, as described in this explanation of botulinum toxin. That description does not specify a product, amount, or schedule for a child.

The NHS overview also describes surgery for selected movement difficulties, tight muscles or connective tissue, and joint problems. NICE's therapy recommendations describe adapted physical therapy as an essential part of management after certain injections and operations. The categories are connected parts of care, rather than isolated decisions made from a general information page.

What the upper-limb review concluded

A 2010 Cochrane review studied botulinum toxin injections for the upper limb in children with spastic cerebral palsy. Upper limb means the arm and hand. The review found support for botulinum toxin type A injections as an addition to planned occupational therapy. It reported benefits for impairment, activity measures, and goal achievement when the combination was compared with occupational therapy alone, but not for quality of life or perceived self-competence.

The review did not support using injections in isolation. It called for further work to identify children most likely to respond and to understand longer-term outcomes and accompanying therapy. These are findings from particular studies and comparisons. They do not establish a personal benefit or determine whether an injection is appropriate for a child with a different pattern of movement difficulty.

The distinction between a change in muscle tone and a change in activity matters when reading the findings. A treatment might be studied using a measure of impairment, an everyday task, or a goal agreed with the family. Those are different questions within the review’s results. The child's team can explain which question a proposed treatment is intended to address.

How a plan is reviewed

NICE describes monitoring response to treatment, changes in spasticity, pain, contractures, and whether individual goals need to change in its monitoring recommendations. The NHS invites questions about a medicine's purpose and potential side effects in its treatment information. The child's own team can explain risks, alternatives, and the review plan for a specific proposal. No category description or research result replaces that conversation.